(Q36938818)
Statements
Phase I/II Study of HSP90 Inhibitor AUY922 and Erlotinib for EGFR-Mutant Lung Cancer With Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (English)
Melissa L Johnson
Helena A Yu
Eric M Hart
Bing Bing Weitner
Alfred W Rademaker
Jyoti D Patel